Nominations Now Open for Biden Cancer FIERCE Awards

The Biden Cancer Initiative today announced a call for nominations for its inaugural FIERCE Awards, recognizing individuals and organizations making a transformative impact on the lives of cancer patients. FIERCE Awards nominations are open through July 31, 2018 and can be submitted at www.bidencancer.org/our-work/fierce-awards/.

Individuals and organizations can be nominated for each of the five award categories: 

1. Prevention and early detection focuses on efforts to raise awareness and reach of effective prevention and early detection strategies and/or the development of more advanced prevention and screening tools. 
2. Reducing cancer disparities highlights efforts focused on ensuring effective cancer care and research efforts are inclusive and accessible to all, particularly underserved communities.
3. Patient navigation spotlights efforts that effectively help cancer patients and their caregivers find their way through the complicated and confusing maze that is the cancer journey.
4. Survivorship looks to those whose work helps the patient through the social-emotional, financial, and/or medical impacts of surviving cancer. 
5. LEAP (Leadership through Exemplary and Awesome Purpose) award recognizes exceptional efforts that transform the way we approach cancer research and care, that improve patient support and patient outcomes, or that accelerate progress against cancer.

“The cancer journey is filled with exceptional people doing exceptional things,” said Dr. Jill Biden, co-chair of the Biden Cancer Initiative. “We created the FIERCE Awards to celebrate the people and organizations that inspire us to be fierce, that help patients thrive, that make hope real.”

The FIERCE Awards will be announced September 20, 2018 in Washington, D.C., at a ceremony designed to open the Biden Cancer Summit.

Organizations and individuals nominated for the FIERCE Awards must be based in the United States, have one year of measurable outcomes, and will be judged by a leading panel of experts on the basis of the implementation of an innovative and collaborative approach that improves outcomes for patients and accelerates progress against cancer in the category of nomination.